UNSPSC 51286302: Picloxydine dihydrochloride

This classfication denotes a topical anti-infective agent with the molecular formula C20H24Cl2N10.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WZK4CO345V, chemically known as 1,1'-(1,4-piperazinediylbis(imidocarbonyl))bis(3-(p-chlorophenyl)guanidine) dihydrochloride, but more generally known as picloxydine dihydrochloride, which bears US NIH Compound Identifier 9578346.

European Medicines Agency schedules picloxydine dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09813MIG. Most nations, for tariff purposes, schedule picloxydine dihydrochloride under HS 29335995. SMILES: C1CC(CCC1NC(=N)NC(=N)N2CCN(CC2)C(=N)NC(=N)NC3CCC(CC3)CL)CL.CL.CL.

UNSPSC 51286302 Picloxydine dihydrochloride is a Commodity code that covers pharmaceutical active pharmaceutical ingredients and finished-form medications, though recent state and local procurement activity under this code shows minimal relevant buying — the two posted opportunities involve doxycycline hyclate, ciprofloxacin hydrochloride, naloxone, and drug deactivation systems rather than picloxydine itself. State and local health departments and county public health authorities are the primary issuing bodies soliciting under related pharmaceutical codes, typically buying finished medications and medical supplies for public health programs, emergency response, and community health initiatives. The Illinois Department of Public Health and Seminole County, Florida represent the issuing-body types active in this space, though neither procurement directly targets the picloxydine commodity named by the code.

Recent activity clusters in Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC (Bid Number 26-482DPH-PREPDB53392, completed August 28, 2026) for doxycycline hyclate and ciprofloxacin hydrochloride across a 12-month initial term with two renewal options. Seminole County, Florida issued an IFB (IFB60459723LAS, posted June 30, 2026, due July 26, 2026) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery requirements to the Seminole County Community Health Building in Sanford. The code shows little recent procurement activity specifically for picloxydine; vendors pursuing this commodity should monitor state department of health and county public health agency RFPs and piggyback cooperative purchasing vehicles, particularly MMCAP Infuse and similar pharmaceutical consortia.